{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:37Z","timestamp":1790268637699,"version":"4.1.0"},"reference-count":40,"publisher":"Impact Journals, LLC","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2017,1,24]]},"DOI":"10.18632\/oncotarget.14043","type":"journal-article","created":{"date-parts":[[2016,12,22]],"date-time":"2016-12-22T16:29:38Z","timestamp":1482424178000},"page":"6102-6113","source":"Crossref","is-referenced-by-count":23,"title":["Idelalisib induces PUMA-dependent apoptosis in colon cancer cells"],"prefix":"10.18632","volume":"8","author":[{"given":"Shida","family":"Yang","sequence":"first","affiliation":[{"name":"Department of Laboratory Medicine, The People's Hospital of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyong","family":"Zhu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The People's Hospital of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The People's Hospital of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Laboratory Medicine, The First Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhicheng","family":"Yao","sequence":"additional","affiliation":[{"name":"Department of Neurology, The People's Hospital of Liaoning Province, Shenyang, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2016,12,20]]},"reference":[{"key":"1","first-page":"115","article-title":"The PI3Kdelta inhibitor idelalisib suppresses liver and lung cellular respiration","volume":"7","author":"Souid","year":"2015","journal-title":"International journal of physiology, pathophysiology and pharmacology"},{"key":"2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1177\/1078155215572933","article-title":"Idelalisib- a PI3Kdelta targeting agent for B-cell malignancies","volume":"22","author":"Shah","year":"2016","journal-title":"Journal of oncology pharmacy practice"},{"key":"3","first-page":"455","article-title":"Idelalisib: The First-in-Class Phosphatidylinositol 3-Kinase Inhibitor for Relapsed CLL, SLL, and Indolent NHL","volume":"5","author":"Saraiya","year":"2014","journal-title":"Journal of the advanced practitioner in oncology"},{"key":"4","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1056\/NEJMoa1315226","article-title":"Idelalisib and rituximab in relapsed chronic lymphocytic leukemia","volume":"370","author":"Ervin","year":"2014","journal-title":"The New England journal of medicine"},{"key":"5","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.3109\/10428194.2015.1022770","article-title":"Management of adverse events associated with idelalisib treatment: expert panel opinion","volume":"56","author":"Zelenetz","year":"2015","journal-title":"Leukemia & lymphoma"},{"key":"6","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1073\/pnas.2627984100","article-title":"PUMA mediates the apoptotic response to p53 in colorectal cancer cells","volume":"100","author":"Zhang","year":"2003","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"7","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1038\/onc.2009.45","article-title":"a potent killer with or without p53","volume":"27","author":"Zhang","year":"2008","journal-title":"Oncogene"},{"key":"8","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1158\/0008-5472.CAN-04-1754","article-title":"PUMA overexpression induces reactive oxygen species generation and proteasome-mediated stathmin degradation in colorectal cancer cells","volume":"65","author":"Hu","year":"2005","journal-title":"Cancer research"},{"key":"9","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.1158\/1078-0432.CCR-05-2429","article-title":"PUMA sensitizes lung cancer cells to chemotherapeutic agents and irradiation","volume":"12","author":"Zhang","year":"2006","journal-title":"Clinical cancer research"},{"key":"10","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1158\/1535-7163.MCT-10-0635","article-title":"PUMA induction by FoxO3a mediates the anticancer activities of the broad-range kinase inhibitor UCN-01","volume":"9","author":"Zhang","year":"2010","journal-title":"Molecular cancer therapeutics"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Wang, Qiu, Dudgeon, Liu, Huang, Zambetti, Yu, Zhang. PUMA is directly activated by NF-kappaB and contributes to TNF-alpha-induced apoptosis. Cell death and differentiation. 2009; 16:1192\u20131202.","DOI":"10.1038\/cdd.2009.51"},{"key":"12","first-page":"2348","article-title":"PUMA mediates EGFR tyrosine kinase inhibitor-induced apoptosis in head and neck cancer cells","volume":"18","author":"Yu","year":"2009","journal-title":"Oncogene"},{"key":"13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10495-010-0538-0","article-title":"Mdm2 inhibition induces apoptosis in p53 deficient human colon cancer cells by activating p73- and E2F1-mediated expression of PUMA and Siva-1","volume":"16","author":"Johnson","year":"2011","journal-title":"Apoptosis"},{"key":"14","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1080\/15384047.2015.1040950","article-title":"Inhibition of AKT\/FoxO3a signaling induced PUMA expression in response to p53-independent cytotoxic effects of H1: A derivative of tetrandrine","volume":"16","author":"Wei","year":"2015","journal-title":"Cancer biology & therapy"},{"key":"15","doi-asserted-by":"crossref","first-page":"16034","DOI":"10.1074\/jbc.M513587200","article-title":"PUMA Dissociates Bax and Bcl-X(L) to induce apoptosis in colon cancer cells","volume":"281","author":"Zhang","year":"2006","journal-title":"The Journal of biological chemistry"},{"key":"16","doi-asserted-by":"crossref","first-page":"3472","DOI":"10.1158\/1078-0432.CCR-13-2944","article-title":"Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis","volume":"20","author":"Zhang","year":"2014","journal-title":"Clinical cancer research"},{"key":"17","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1158\/1535-7163.MCT-13-0846","article-title":"Aurora kinase inhibition induces PUMA via NF-kappaB to kill colon cancer cells","volume":"13","author":"Zhang","year":"2014","journal-title":"Molecular cancer therapeutics"},{"key":"18","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1038\/378785a0","article-title":"Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B","volume":"378","author":"Hemmings","year":"1995","journal-title":"Nature"},{"key":"19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.molcel.2005.06.009","article-title":"Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin","volume":"19","author":"Lai","year":"2005","journal-title":"Mol Cell"},{"key":"20","doi-asserted-by":"publisher","first-page":"239","DOI":"10.18632\/oncotarget.242","article-title":"Mcl-1 ubiquitination and destruction","volume":"2","author":"Wei","year":"2011","journal-title":"Oncotarget"},{"key":"21","article-title":"Outcomes of patients with chronic lymphocytic leukemia treated with first-line idelalisib plus rituximab after cessation of treatment for toxicity","author":"O'Brien","year":"2016","journal-title":"Cancer"},{"key":"22","doi-asserted-by":"crossref","first-page":"2411","DOI":"10.1182\/blood-2015-12-683516","article-title":"Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL","volume":"127","author":"Di Paolo","year":"2016","journal-title":"Blood"},{"key":"23","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1182\/blood-2015-03-630947","article-title":"A phase 2 study of idelalisib plus rituximab in treatment-naive older patients with chronic lymphocytic leukemia","volume":"126","author":"Kim","year":"2015","journal-title":"Blood"},{"key":"24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21332","article-title":"Cancer statistics, 2016","volume":"66","author":"Jemal","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"25","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/annonc\/mdp130","article-title":"Advanced colorectal cancer: ESMO clinical recommendations for diagnosis, treatment and follow-up","volume":"20","author":"Group","year":"2009","journal-title":"Annals of oncology"},{"key":"26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1463-1318.2010.02439.x","article-title":"Review of biomarkers in colorectal cancer","volume":"14","author":"Hill","year":"2012","journal-title":"Colorectal disease"},{"key":"27","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1634\/theoncologist.11-9-981","article-title":"Therapy for metastatic colorectal cancer","volume":"11","author":"Goldberg","year":"2006","journal-title":"The oncologist"},{"key":"28","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2146\/ajhp150281","article-title":"Idelalisib for treatment of B-cell malignancies","volume":"73","author":"Rexwinkle","year":"2016","journal-title":"American journal of health-system pharmacy"},{"key":"29","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/annonc\/mdw029","article-title":"Breakthrough therapies in B-cell non-Hodgkin lymphoma","volume":"27","author":"Wang","year":"2016","journal-title":"Annals of oncology"},{"key":"30","article-title":"FBW7 mutations mediate resistance of colorectal cancer to targeted therapies by blocking Mcl-1 degradation","author":"Zhang","year":"2016","journal-title":"Oncogene"},{"key":"31","doi-asserted-by":"crossref","unstructured":"Peng, Tong, Li, Yue, Zou, Yu, Zhang. Targeting Bax interaction sites reveals that only homo-oligomerization sites are essential for its activation. Cell death and differentiation. 2013; 20:744\u2013754.","DOI":"10.1038\/cdd.2013.4"},{"key":"32","doi-asserted-by":"crossref","first-page":"8305","DOI":"10.1038\/ncomms9305","article-title":"Vertical suppression of the EGFR pathway prevents onset of resistance in colorectal cancers","volume":"6","author":"Zhang","year":"2015","journal-title":"Nature communications"},{"key":"33","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1126\/science.1206727","article-title":"Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy","volume":"334","author":"Drapkin","year":"2011","journal-title":"Science"},{"key":"34","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1038\/nrclinonc.2013.110","article-title":"Liquid biopsy: monitoring cancer-genetics in the blood","volume":"10","author":"Bardelli","year":"2013","journal-title":"Nat Rev Clin Oncol"},{"key":"35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1600-6143.2012.04281.x","article-title":"Inhibitors of mTOR and risks of allograft failure and mortality in kidney transplantation","volume":"13","author":"Wolf","year":"2013","journal-title":"American journal of transplantation"},{"key":"36","doi-asserted-by":"crossref","first-page":"e16781","DOI":"10.1371\/journal.pone.0016781","article-title":"Icaritin causes sustained ERK1\/2 activation and induces apoptosis in human endometrial cancer cells","volume":"6","author":"Sun","year":"2011","journal-title":"PloS one"},{"key":"37","doi-asserted-by":"crossref","first-page":"e15408","DOI":"10.1371\/journal.pone.0015408","article-title":"ER-alpha36, a novel variant of ER-alpha, mediates estrogen-stimulated proliferation of endometrial carcinoma cells via the PKCdelta\/ERK pathway","volume":"5","author":"Sun","year":"2010","journal-title":"PloS one"},{"key":"38","doi-asserted-by":"publisher","first-page":"47699","DOI":"10.18632\/oncotarget.10277","article-title":"BRAFV600E-dependent Mcl-1 stabilization leads to everolimus resistance in colon cancer cells","volume":"7","author":"Yu","year":"2016","journal-title":"Oncotarget"},{"key":"39","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1038\/ncomms2254","article-title":"The RB family is required for the self-renewal and survival of human embryonic stem cells","volume":"3","author":"Sage","year":"2012","journal-title":"Nature communications"},{"key":"40","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.3892\/mmr.2014.1981","article-title":"c-Jun transactivates Puma gene expression to promote osteoarthritis","volume":"9","author":"Zhao","year":"2014","journal-title":"Molecular medicine reports"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14043","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,6]],"date-time":"2020-08-06T14:09:56Z","timestamp":1596722996000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.14043"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12,20]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,1,24]]}},"alternative-id":["14043","28008149"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.14043","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,12,20]]}}}